Literature DB >> 16253017

Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability.

Adrian Gologan1, Alyssa Krasinskas, Jennifer Hunt, Darcy L Thull, Linda Farkas, Antonia R Sepulveda.   

Abstract

CONTEXT: Criteria for microsatellite instability (MSI) testing to rule out hereditary nonpolyposis colorectal cancer were recently revised and include parameters such as age and specific histologic features that can be identified by the pathologist, triggering reflex MSI testing.
OBJECTIVE: To review the performance of the revised Bethesda guidelines to identify MSI-positive colorectal cancers.
DESIGN: Seventy-five patients with colorectal cancer were included; 68 patients younger than 50 years and 7 patients between 50 and 60 years were selected based on histopathologic criteria. Microsatellite instability testing with the National Cancer Institute--recommended panel and immunohistochemistry for hMLH1 and hMSH2 were performed. Tumors were classified into microsatellite instability high (MSI-H), low (MSI-L), or stable (MSS) categories.
RESULTS: Overall, 17 (23%) of 75 colorectal cancer cases were classified as MSI-H, including 13 patients younger than 50 years and 4 patients between 50 and 60 years. Among the MSI-H tumors, 10 (59%) were characterized by loss of hMLH1 and 6 (35%) were hMSH2 negative. Histologic features suggestive of MSI-H phenotype were present in 80% of MSI-H and 35% of MSS/MSI-L tumors. The number of positive lymph nodes was higher in MSS/MSI-L adenocarcinomas (P = .04).
CONCLUSIONS: By selecting for age and histologic features, we detected MSI-H tumors in approximately one quarter of colorectal cancer cases meeting the revised Bethesda guidelines and identified 17 MSI-H cases, whereas only 8 would have been recognized by the prior guidelines. These data indicate that reflex testing requested by pathologists based on the revised Bethesda guidelines increases the detection of MSI-H and potential hereditary nonpolyposis colorectal cancer cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253017     DOI: 10.5858/2005-129-1390-POTRBG

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  16 in total

1.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program.

Authors:  Aparna Mukherjee; Thomas J McGarrity; Francesca Ruggiero; Walter Koltun; Kevin McKenna; Lisa Poritz; Maria J Baker
Journal:  Hered Cancer Clin Pract       Date:  2010-11-22       Impact factor: 2.857

3.  Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.

Authors:  Miguel Serrano; Pedro Lage; Sara Belga; Bruno Filipe; Inês Francisco; Paula Rodrigues; Ricardo Fonseca; Paula Chaves; Isabel Claro; Cristina Albuquerque; António Dias Pereira
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

4.  Recommendations for the reporting of surgically resected specimens of colorectal carcinoma.

Authors:  Jeremy R Jass; Michael J O'Brien; Robert H Riddell; Dale C Snover
Journal:  Virchows Arch       Date:  2006-11-25       Impact factor: 4.064

Review 5.  Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Authors:  Jeremy R Jass
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

6.  Q48P mutation in the hMLH1 gene associated with Lynch syndrome in three Hungarian families.

Authors:  Miklós Tanyi; Judit Olasz; Janos L Tanyi; László Tóth; Péter Antal-Szalmás; Tamás Bubán; Csilla András; Hilda Urbancsek; Zoltán Garami; Orsolya Csuka; László Damjanovich
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

7.  Proficiency of DNA repair genes and microsatellite instability in operated colorectal cancer patients with clinical suspicion of lynch syndrome.

Authors:  Isabella Nicácio de Freitas; Fábio Guilherm Caserta Maryssael de Campos; Venâncio Avancini Ferreira Alves; Juliana Magalhães Cavalcante; Dirce Carraro; Renata de Almeida Coudry; Márcio Augusto Diniz; Sérgio Carlos Nahas; Ulysses Ribeiro
Journal:  J Gastrointest Oncol       Date:  2015-12

Review 8.  Genomic and genetic alterations influence the progression of gastric cancer.

Authors:  Stefania Nobili; Lorenzo Bruno; Ida Landini; Cristina Napoli; Paolo Bechi; Francesco Tonelli; Carlos A Rubio; Enrico Mini; Gabriella Nesi
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

9.  Tumor histology helps to identify Lynch syndrome among colorectal cancer patients.

Authors:  Brindusa Truta; Yunn-Yi Chen; Amie M Blanco; Guoren Deng; Peggy G Conrad; Yong Ho Kim; Eun Taek Park; Sanjay Kakar; Young S Kim; Fernando Velayos; Marvin H Sleisenger; Jonathan P Terdiman
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

10.  DICER1 and PRKRA in Colon Adenocarcinoma.

Authors:  S Chiosea; M Acquafondata; J Luo; Sf Kuan; Rr Seethala
Journal:  Biomark Insights       Date:  2008-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.